• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW ORTHOPAEDICS LTD BHR DYSPLASIA CUP 46MM; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW ORTHOPAEDICS LTD BHR DYSPLASIA CUP 46MM; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING Back to Search Results
Catalog Number 74120246
Medical Device Problem Code Appropriate Device Problem Term/Code Not Available (3191)
Health Effect - Clinical Codes Failure of Implant (1924); Pain (1994); Toxicity (2333)
Date of Event 03/27/2017
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that left hip revision surgery was performed due to pain and metallosis.
 
Additional Manufacturer Narrative
This is a legal complaint reporting a revision of a metal on metal hip due to pain and metallosis.As of today, device return and additional information has been requested for this complaint but has not become available.In the absence of the actual devices, the production records were reviewed for the devices reportedly involved in this incident.Review of manufacturing records did not reveal any waivers, concessions, manufacturing or material abnormalities that could have contributed to this issue.The supplied medical information was reviewed.Based on the provided documents, pain of the left hip started approximately 1.5 years before the revision and approximately 8 years after the implantation.Review of the provided implantation report (2008) indicates that only half of the leg-length discrepancy was restored by the hip replacement and was then noted to be ¿approximately equal¿ 8 years later in a noted x-ray report in 2016.According to the provided reports dated 2 months before the revision, the blood chromium (3.1 g/l, reference: <1.5 g/l) concentration was high with respect to the given reference and blood cobalt was normal (1.1 g/l, reference: <1.9 g/l).It remains unclear whether the measurements were performed in serum or whole blood.Therefore, a comparison to for example the limits from the mhra ((b)(4)) cannot be done.The provide mri report dated 5 months before the revision did not indicate any adverse findings.According to the surgical report of the revision, there was ¿significant amount of inflammatory-like synovitis associate with the hip¿ and no signs of infection (based on intra-operative observations and a mentioned pre-operative aspirate).I was also reported that there were no elevated inflammatory markers found in the synovial fluid sampled.Excised tissue was sent for analysis to investigate a potential metallosis.The corresponding report and any results were not provided.Based on the available documents metallosis cannot be confirmed but only that there was an inflammatory synovitis, and the intra-operative observations did not note other findings consistent with a metallosis reaction.As no x-rays were provided, a potential involvement of the implant position with the reported findings cannot be assessed.The root cause of the patient¿s pain cannot be concluded.Without return of the actual devices or further information we cannot further investigate or confirm the details supplied in this complaint.If the products or additional information become available in the future, this case will be reopened.Without additional information about this patient¿s particular case, our investigation remains inconclusive.No preventative or corrective action has been initiated as a result of this investigation.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BHR DYSPLASIA CUP 46MM
Common Device Name
PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING
Manufacturer (Section D)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house
spa park
leamington spa CV31 3HL
UK  CV31 3HL
MDR Report Key6688881
Report Number3005975929-2017-00195
Device Sequence Number13463598
Product Code NXT
UDI-Device Identifier03596010502650
UDI-Public03596010502650
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
P040033
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2008
Device Explanted Year2017
Reporter Type Manufacturer
Report Source consumer,other
Initial Reporter Occupation Attorney
Type of Report Initial,Followup
Report Date (Section B) 10/03/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date07/31/2010
Device Catalogue Number74120246
Device Lot Number52134
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 06/27/2017
Supplement Date Received by Manufacturer06/27/2017
Initial Report FDA Received Date07/06/2017
Supplement Report FDA Received Date10/03/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
DYSPLASIA SCREW, # 74500036, LOT # 06AM12134; DYSPLASIA SCREW, # 74500040, LOT # 07HM13544; FEMORAL STEM, # 71357001, LOT # 06AM02717A; HEMI HEAD, # 74122538, LOT # 10686; MODULAR SLEEVE, # 74222100, LOT # 07FW12477
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age33 YR
-
-